Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 515

1.

2017 American Academy of Pediatrics Clinical Practice Guideline: Impact on Prevalence of Arterial Hypertension in Children and Adolescents With Type 1 Diabetes.

Dost A, Bechtold S, Fink K, Bonfig W, Wiemann D, Kapellen TM, Witsch M, Schwab KO, Holl RW; initiative DPV-Science and the German Diabetes Research Center.

Diabetes Care. 2020 Mar 30. pii: dc192022. doi: 10.2337/dc19-2022. [Epub ahead of print]

PMID:
32229598
2.

A Bayesian Adaptive Randomized Phase II Multicenter Trial of Bevacizumab with or without Vorinostat in Adults with Recurrent Glioblastoma.

Puduvalli VK, Wu J, Yuan Y, Armstrong TS, Vera E, Wu J, Xu J, Giglio P, Colman H, Walbert T, Raizer J, Groves MD, Tran D, Iwamoto F, Avgeropoulos N, Paleologos N, Fink K, Peereboom D, Chamberlain M, Merrell R, Penas Prado M, Yung WKA, Gilbert MR.

Neuro Oncol. 2020 Mar 13. pii: noaa062. doi: 10.1093/neuonc/noaa062. [Epub ahead of print]

PMID:
32166308
3.

Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome.

Berg EL, Pride MC, Petkova SP, Lee RD, Copping NA, Shen Y, Adhikari A, Fenton TA, Pedersen LR, Noakes LS, Nieman BJ, Lerch JP, Harris S, Born HA, Peters MM, Deng P, Cameron DL, Fink KD, Beitnere U, O'Geen H, Anderson AE, Dindot SV, Nash KR, Weeber EJ, Wöhr M, Ellegood J, Segal DJ, Silverman JL.

Transl Psychiatry. 2020 Jan 27;10(1):39. doi: 10.1038/s41398-020-0720-2.

4.

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients.

Alping P, Askling J, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, Frisell T.

Ann Neurol. 2020 Feb 13. doi: 10.1002/ana.25701. [Epub ahead of print]

PMID:
32056253
5.

Prospective evaluation of the quickSOFA score as a screening for sepsis in the emergency department.

Loritz M, Busch HJ, Helbing T, Fink K.

Intern Emerg Med. 2020 Feb 8. doi: 10.1007/s11739-019-02258-2. [Epub ahead of print]

PMID:
32036543
6.

Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.

Reardon DA, Desjardins A, Vredenburgh JJ, O'Rourke DM, Tran DD, Fink KL, Nabors LB, Li G, Bota DA, Lukas RV, Ashby LS, Duic JP, Mrugala MM, Cruickshank S, Vitale L, He Y, Green JA, Yellin MJ, Turner CD, Keler T, Davis TA, Sampson JH; ReACT trial investigators.

Clin Cancer Res. 2020 Apr 1;26(7):1586-1594. doi: 10.1158/1078-0432.CCR-18-1140. Epub 2020 Feb 7.

PMID:
32034072
7.

Artificial escape from XCI by DNA methylation editing of the CDKL5 gene.

Halmai JANM, Deng P, Gonzalez CE, Coggins NB, Cameron D, Carter JL, Buchanan FKB, Waldo JJ, Lock SR, Anderson JD, O'Geen H, Segal DJ, Nolta J, Fink KD.

Nucleic Acids Res. 2020 Mar 18;48(5):2372-2387. doi: 10.1093/nar/gkz1214.

8.

Structural Evolution of Palladium Clusters Pd55--Pd147-: Transition to the Bulk.

Kohaut S, Rapps T, Fink K, Schooss D.

J Phys Chem A. 2019 Dec 26;123(51):10940-10946. doi: 10.1021/acs.jpca.9b09369. Epub 2019 Dec 12.

PMID:
31769986
9.

Large-Scale HLA Tetramer Tracking of T Cells during Dengue Infection Reveals Broad Acute Activation and Differentiation into Two Memory Cell Fates.

Chng MHY, Lim MQ, Rouers A, Becht E, Lee B, MacAry PA, Lye DC, Leo YS, Chen J, Fink K, Rivino L, Newell EW.

Immunity. 2019 Dec 17;51(6):1119-1135.e5. doi: 10.1016/j.immuni.2019.10.007. Epub 2019 Nov 19.

PMID:
31757672
10.

Temporal release of a three-component protein subunit vaccine from polymer multilayers.

Uppu DSSM, Turvey ME, Sharif ARM, Bidet K, He Y, Ho V, Tambe AD, Lescar J, Tan EY, Fink K, Chen J, Hammond PT.

J Control Release. 2020 Jan 10;317:130-141. doi: 10.1016/j.jconrel.2019.11.022. Epub 2019 Nov 20.

PMID:
31756392
11.

MRI-Based Manual versus Automated Corpus Callosum Volumetric Measurements in Multiple Sclerosis.

Platten M, Martola J, Fink K, Ouellette R, Piehl F, Granberg T.

J Neuroimaging. 2020 Mar;30(2):198-204. doi: 10.1111/jon.12676. Epub 2019 Nov 20.

PMID:
31750599
12.

Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity.

Juto A, Fink K, Al Nimer F, Piehl F.

Mult Scler Relat Disord. 2020 Jan;37:101468. doi: 10.1016/j.msard.2019.101468. Epub 2019 Oct 24.

PMID:
31683231
13.

Electron Ionization of Imidazole and Its Derivative 2-Nitroimidazole.

Meißner R, Feketeová L, Ribar A, Fink K, Limão-Vieira P, Denifl S.

J Am Soc Mass Spectrom. 2019 Dec;30(12):2678-2691. doi: 10.1007/s13361-019-02337-w. Epub 2019 Oct 30.

14.

Erratum: Author Correction: Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.

Bidet K, Ho V, Chu CW, Naim ANM, Thazin K, Chan KR, Low JGH, Choy MM, Wong LH, de Sessions PF, Lee YH, Hibberd ML, Ooi EE, Fink K, Chen J.

NPJ Vaccines. 2019 Oct 24;4:46. doi: 10.1038/s41541-019-0140-6. eCollection 2019.

15.

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

Luna G, Alping P, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, Frisell T.

JAMA Neurol. 2019 Oct 7. doi: 10.1001/jamaneurol.2019.3365. [Epub ahead of print]

PMID:
31589278
16.

Lack of in-home piped water and reported consumption of sugar-sweetened beverages among adults in rural Alaska.

Mosites E, Seeman S, Fenaughty A, Fink K, Eichelberger L, Holck P, Thomas TK, Bruce MG, Hennessy TW.

Public Health Nutr. 2020 Apr;23(5):861-868. doi: 10.1017/S1368980019002477. Epub 2019 Sep 24.

17.

Blood Vessel Patterning on Retinal Astrocytes Requires Endothelial Flt-1 (VEGFR-1).

Chappell JC, Darden J, Payne LB, Fink K, Bautch VL.

J Dev Biol. 2019 Sep 7;7(3). pii: E18. doi: 10.3390/jdb7030018.

18.

Metallacarboranes as a tool for enhancing the activity of therapeutic peptides.

Fink K, Boratyński J, Paprocka M, Goszczyński TM.

Ann N Y Acad Sci. 2019 Dec;1457(1):128-141. doi: 10.1111/nyas.14201. Epub 2019 Aug 12.

PMID:
31407357
19.

A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.

Ong SM, Teng K, Newell E, Chen H, Chen J, Loy T, Yeo TW, Fink K, Wong SC.

Front Immunol. 2019 Jul 26;10:1761. doi: 10.3389/fimmu.2019.01761. eCollection 2019.

20.

Structure-guided design of immunomodulatory RNAs specifically targeting the cytoplasmic viral RNA sensor RIG-I.

Yong HY, Zheng J, Ho VCY, Nguyen MT, Fink K, Griffin PR, Luo D.

FEBS Lett. 2019 Nov;593(21):3003-3014. doi: 10.1002/1873-3468.13564. Epub 2019 Aug 19.

PMID:
31369683
21.

Adult Primary Peripheral PNET/Ewing's Sarcoma of the Cervical and Thoracic Spine.

Khwaja R, Mantilla E, Fink K, Pan E.

Anticancer Res. 2019 Aug;39(8):4463-4465. doi: 10.21873/anticanres.13619.

PMID:
31366545
22.

[Freiburg Cardiac Arrest Receiving Team (CART) : Interdisciplinary solution for the acute management of non-traumatic out-of-hospital cardiac arrest].

Busch HJ, Schmid B, Kron J, Fink K, Busche C, Danner T, Veits O, Gottlieb D, Benk C, Trummer G, Meyer-Först S, Kopp S, Schwab W, Wengenmayer T, Biever P.

Med Klin Intensivmed Notfmed. 2019 Jul 30. doi: 10.1007/s00063-019-0598-z. [Epub ahead of print] German.

PMID:
31363800
23.

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.

Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert JM, LaRocca R, O'Rourke DM, Fink K, Kim L, Gruber M, Lesser GJ, Pan E, Kesari S, Muzikansky A, Pinilla C, Santos RG, Yu JS.

Clin Cancer Res. 2019 Oct 1;25(19):5799-5807. doi: 10.1158/1078-0432.CCR-19-0261. Epub 2019 Jul 18.

PMID:
31320597
24.

Altered monocyte response to the dengue virus in those with varying severity of past dengue infection.

Kamaladasa A, Gomes L, Wijesinghe A, Jeewandara C, Toh YX, Jayathilaka D, Ogg GS, Fink K, Malavige GN.

Antiviral Res. 2019 Sep;169:104554. doi: 10.1016/j.antiviral.2019.104554. Epub 2019 Jul 6.

PMID:
31288040
25.

Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.

Bidet K, Ho V, Chu CW, Naim ANH, Thazin K, Chan KR, Low JGH, Choy MM, Wong LH, Florez de Sessions P, Lee YH, Hibberd ML, Ooi EE, Fink K, Chen J.

NPJ Vaccines. 2019 Jun 25;4:27. doi: 10.1038/s41541-019-0119-3. eCollection 2019. Erratum in: NPJ Vaccines. 2019 Aug 13;4:36. NPJ Vaccines. 2019 Oct 24;4:46.

26.

Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice.

Hou J, Shrivastava S, Fraser CC, Loo HL, Wong LH, Ho V, Fink K, Ooi EE, Chen J.

Front Immunol. 2019 Jun 20;10:1429. doi: 10.3389/fimmu.2019.01429. eCollection 2019.

27.

Rational Design of Iron Oxide Binding Peptide Tags.

Schwaminger SP, Anand P, Borkowska-Panek M, Blank-Shim SA, Fraga-Garci A P, Fink K, Berensmeier S, Wenzel W.

Langmuir. 2019 Jun 25;35(25):8472-8481. doi: 10.1021/acs.langmuir.9b00729. Epub 2019 Jun 14.

PMID:
31198043
28.

[Postcardiac arrest treatment guide].

Storm C, Behringer W, Wolfrum S, Michels G, Fink K, Kill C, Arrich J, Leithner C, Ploner C, Busch HJ.

Med Klin Intensivmed Notfmed. 2019 Jun 13. doi: 10.1007/s00063-019-0591-6. [Epub ahead of print] Review. German.

PMID:
31197420
29.

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment.

Bedri SK, Nilsson OB, Fink K, Månberg A, Hamsten C, Ayoglu B, Manouchehrinia A, Nilsson P, Olsson T, Hillert J, Grönlund H, Glaser A.

PLoS One. 2019 May 29;14(5):e0217208. doi: 10.1371/journal.pone.0217208. eCollection 2019.

30.

NRF2 activation with Protandim attenuates salt-induced vascular dysfunction and microvascular rarefaction.

Priestley JRC, Fink KE, McCord JM, Lombard JH.

Microcirculation. 2019 Oct;26(7):e12575. doi: 10.1111/micc.12575. Epub 2019 Jun 19.

PMID:
31132190
31.

Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.

O'Geen H, Bates SL, Carter SS, Nisson KA, Halmai J, Fink KD, Rhie SK, Farnham PJ, Segal DJ.

Epigenetics Chromatin. 2019 May 3;12(1):26. doi: 10.1186/s13072-019-0275-8.

32.

RIG-I Activation by a Designer Short RNA Ligand Protects Human Immune Cells against Dengue Virus Infection without Causing Cytotoxicity.

Ho V, Yong HY, Chevrier M, Narang V, Lum J, Toh YX, Lee B, Chen J, Tan EY, Luo D, Fink K.

J Virol. 2019 Jun 28;93(14). pii: e00102-19. doi: 10.1128/JVI.00102-19. Print 2019 Jul 15.

33.

Studies on B Cells in the Fruit-Eating Black Flying Fox (Pteropus alecto).

Periasamy P, Hutchinson PE, Chen J, Bonne I, Shahul Hameed SS, Selvam P, Hey YY, Fink K, Irving AT, Dutertre CA, Baker M, Crameri G, Wang LF, Alonso S.

Front Immunol. 2019 Mar 14;10:489. doi: 10.3389/fimmu.2019.00489. eCollection 2019.

34.

Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation.

Showalter MR, Wancewicz B, Fiehn O, Archard JA, Clayton S, Wagner J, Deng P, Halmai J, Fink KD, Bauer G, Fury B, Perotti NH, Apperson M, Butters J, Belafsky P, Farwell G, Kuhn M, Nolta JA, Anderson JD.

Biochem Biophys Res Commun. 2019 May 14;512(4):729-735. doi: 10.1016/j.bbrc.2019.03.119. Epub 2019 Mar 26.

35.

Semaphorin 3F Promotes Transendothelial Migration of Leukocytes in the Inflammatory Response After Survived Cardiac Arrest.

Reichert S, Scheid S, Roth T, Herkel M, Petrova D, Linden A, Weberbauer M, Esser J, Diehl P, Grundmann S, Busch HJ, Fink K, Bode C, Moser M, Helbing T.

Inflammation. 2019 Aug;42(4):1252-1264. doi: 10.1007/s10753-019-00985-4.

PMID:
30877507
36.

Can We Improve Vaccine Efficacy by Targeting T and B Cell Repertoire Convergence?

Fink K.

Front Immunol. 2019 Feb 13;10:110. doi: 10.3389/fimmu.2019.00110. eCollection 2019. Review.

37.

Applying the disgust conditioning model of food avoidance: A case study of acceptance-based interoceptive exposure.

Plasencia M, Sysko R, Fink K, Hildebrandt T.

Int J Eat Disord. 2019 Apr;52(4):473-477. doi: 10.1002/eat.23045. Epub 2019 Feb 22.

PMID:
30793778
38.

A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma.

Huang J, Chaudhary R, Cohen AL, Fink K, Goldlust S, Boockvar J, Chinnaiyan P, Wan L, Marcus S, Campian JL.

J Neurooncol. 2019 May;142(3):537-544. doi: 10.1007/s11060-019-03125-y. Epub 2019 Feb 15.

PMID:
30771200
39.

Design, Construction, and Application of Transcription Activation-Like Effectors.

Deng P, Carter S, Fink K.

Methods Mol Biol. 2019;1937:47-58. doi: 10.1007/978-1-4939-9065-8_3.

PMID:
30706389
40.

Spatial memory in Huntington's disease: A comparative review of human and animal data.

Glikmann-Johnston Y, Fink KD, Deng P, Torrest A, Stout JC.

Neurosci Biobehav Rev. 2019 Mar;98:194-207. doi: 10.1016/j.neubiorev.2019.01.015. Epub 2019 Jan 15. Review.

PMID:
30658070
41.

Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion.

Yuan O, Lin C, Wagner J, Archard JA, Deng P, Halmai J, Bauer G, Fink KD, Fury B, Perotti NH, Walker JE, Pollock K, Apperson M, Butters J, Belafsky P, Farwell DG, Kuhn M, Nolta J, Anderson JD.

Stem Cells Dev. 2019 Mar 15;28(6):398-409. doi: 10.1089/scd.2018.0200. Epub 2019 Feb 26.

42.

Synthesis and Biological Activity of Thymosin β4-Anionic Boron Cluster Conjugates.

Fink K, Kobak K, Kasztura M, Boratyński J, Goszczyński TM.

Bioconjug Chem. 2018 Nov 21;29(11):3509-3515. doi: 10.1021/acs.bioconjchem.8b00646. Epub 2018 Oct 30.

PMID:
30365887
43.

Counseling Patients About Prostate Cancer Screening.

Stevermer JJ, Fink KS.

Am Fam Physician. 2018 Oct 15;98(8):478-483. No abstract available.

44.

Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis.

Guo C, Ferreira D, Fink K, Westman E, Granberg T.

Eur Radiol. 2019 Mar;29(3):1355-1364. doi: 10.1007/s00330-018-5710-x. Epub 2018 Sep 21.

45.

TLR9-mediated activation of dendritic cells by CD32 targeting for the generation of highly immunostimulatory vaccines.

Sepulveda-Toepfer JA, Pichler J, Fink K, Sevo M, Wildburger S, Mudde-Boer LC, Taus C, Mudde GC.

Hum Vaccin Immunother. 2019;15(1):179-188. doi: 10.1080/21645515.2018.1514223. Epub 2018 Sep 19.

46.

Position Paper on Road Map for RNA Virus Research in India.

Medigeshi GR, Fink K, Hegde NR.

Front Microbiol. 2018 Jul 31;9:1753. doi: 10.3389/fmicb.2018.01753. eCollection 2018.

47.

Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.

Shan C, Xie X, Zou J, Züst R, Zhang B, Ambrose R, Mackenzie J, Fink K, Shi PY.

J Virol. 2018 Oct 12;92(21). pii: e01002-18. doi: 10.1128/JVI.01002-18. Print 2018 Nov 1.

48.

Icosahedral boron clusters as modifying entities for biomolecules.

Goszczyński TM, Fink K, Boratyński J.

Expert Opin Biol Ther. 2018 Jul;18(sup1):205-213. doi: 10.1080/14712598.2018.1473369. Review.

PMID:
30063861
49.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 Jun 29;16(1):179. doi: 10.1186/s12967-018-1552-1.

50.

Applicability of McDonald 2010 and Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) 2016 Magnetic Resonance Imaging Criteria for the Diagnosis of Multiple Sclerosis in Sri Lanka.

Gamage SMK, Wijeweera I, Wijesinghe P, Adikari SB, Fink K, Sominanda HMA.

J Clin Neurol. 2018 Jul;14(3):339-344. doi: 10.3988/jcn.2018.14.3.339. Epub 2018 May 31.

Supplemental Content

Support Center